Caroline Agnes Cantalin, AGPCNP | |
8225 Clayton Rd, Clayton, MO 63117-1107 | |
(314) 330-4776 | |
Not Available |
Full Name | Caroline Agnes Cantalin |
---|---|
Gender | Female |
Speciality | General Practice |
Location | 8225 Clayton Rd, Clayton, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770271363 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 2023013712 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Caroline Agnes Cantalin, AGPCNP 8225 Clayton Rd, Saint Louis, MO 63117-1107 Ph: (314) 368-7487 | Caroline Agnes Cantalin, AGPCNP 8225 Clayton Rd, Clayton, MO 63117-1107 Ph: (314) 330-4776 |
News Archive
An international team of multiple sclerosis (MS) experts has identified four under-researched areas that are critical to advancing symptom management for progressive MS, recommending interdisciplinary collaboration among scientists, clinicians, industry leaders, and those with progressive MS.
Alzheimer's is a progressive brain disease that affects older adults, slowly destroys their memories and may cause dementia. According to estimates from the National Institutes of Health (NIH), the disease may affect as many as 5.1 million Americans.
HealthInsight, provider of the only value-based health care administration platform, officially unveils a set of technology and services for health insurers, third-party administrators and employers that are proven to lower overall medical costs while improving the quality of care. The new platform will be used to determine and track health actions that are directly tied to benefit designs, which is instrumental in lowering health care costs.
Argos Therapeutics today announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium.
A new study led by University of Kentucky researcher April Young and Emory University researcher Hannah Cooper shows that a number of pharmacies in the Appalachian region of Kentucky are limiting the dispensing of buprenorphine, a medication used to treat opioid use disorder.
› Verified 2 days ago